Ovid Therapeutics Inc. (OVID)
undefined
undefined%
At close: undefined
1.04
1.05%
After-hours Dec 13, 2024, 04:31 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue 391.69K 1.50M 208.38M 12.62M - - - - - -
Cost of Revenue - 1.38M - - 255.00K 141.73K 80.31K 56.51K 11.78K -
Gross Profit 391.69K 121.14K 208.38M 12.62M -255.00K -141.73K -80.31K -56.51K -11.78K -
Operating Income -59.28M -55.55M 124.21M -81.43M -61.41M -52.93M -65.01M -22.54M -13.19M -446.89K
Interest Income 4.90M - - 395.40K 948.22K 952.07K 201.51K - 30.28K -
Pretax Income -52.34M -54.17M 124.16M -81.04M -60.46M -51.98M -64.81M -22.41M -13.16M -446.89K
Net Income -52.34M -51.41M 122.83M -80.73M -59.26M -51.98M -64.81M -22.41M -13.16M -446.89K
Selling & General & Admin 31.09M 32.43M 37.23M 30.63M 19.25M 19.14M 15.04M 12.95M 6.58M 341.52K
Research & Development 28.59M 24.62M 46.94M 63.42M 42.16M 33.79M 49.97M 9.59M 6.61M 105.38K
Other Expenses 1.00 1.38M -45.69K 395.40K - - - - - -
Operating Expenses 59.67M 57.05M 84.17M 94.05M 61.41M 52.93M 65.01M 22.54M 13.19M 446.89K
Interest Expense - - - - - - - - - -
Selling & Marketing Expenses - - - - - - - - - -
Cost & Expenses 59.67M 57.05M 84.17M 94.05M 61.41M 52.93M 65.01M 22.54M 13.19M 446.89K
Income Tax - -2.76M 1.33M -306.85K -1.20M 951.73K -80.31K -950 - -
Shares Outstanding (Basic) 70.58M 70.42M 67.48M 58.45M 39.22M 24.63M 19.34M 19.60M 19.60M 4.75M
Shares Outstanding (Diluted) 70.58M 70.42M 68.07M 58.45M 39.22M 24.63M 19.34M 19.60M 19.60M 4.75M
EPS (Basic) -0.74 -0.73 1.78 -1.38 -1.51 -2.11 -3.35 -1.14 -0.67 -0.09
EPS (Diluted) -0.74 -0.73 1.78 -1.38 -1.51 -2.11 -3.35 -1.14 -0.67 -0.09
EBITDA -58.71M -52.79M 124.40M -81.12M -60.21M -52.79M -64.73M -22.48M -13.18M -444.58K
Depreciation & Amortization 1.60M 1.38M 237.00K 307.00K 255.00K 141.73K 80.31K 56.51K 11.78K 2.31K